Novel Substituted Amino-, Imino-1,2,4 Triazine Derivatives

Simple SummaryContent extracted from patent full text and abstract with AI.

This patent describes a new class of substituted amino- and imino-1,2,4-triazine derivatives, as well as pharmaceutical preparations containing these compounds. The compounds are designed as potent, non-opioid analgesic agents with central and peripheral action to treat various types of pain, including acute and chronic, neuropathic, inflammatory, and cancer-related pain. The compounds also show potential as muscle relaxants and for other neurological uses, with their mechanism believed to involve potassium channel agonism, distinguishing them from traditional opioid drugs.

Use CasesContent extracted from patent full text and abstract with AI.

• Treatment of acute, chronic, neuropathic, and cancer-related pain (e.g., migraines, postoperative pain, arthritis pain, tumor pain)
• Muscle relaxation for conditions involving muscle tension or spasms
• Management of pain associated with inflammation, burns, or injuries
• Alternative to opioid-based pain medications for patients at risk of addiction
• Adjunct therapy in pain management regimens, possibly in combination with other analgesics
• Potential preventive and therapeutic use for menstrual pain (dysmenorrhea), headaches, and dental pain

BenefitsContent extracted from patent full text and abstract with AI.

• Provides potent analgesic (pain-relieving) effects without using opioids, reducing risk of addiction and typical opioid side effects
• Shows efficacy against both centrally and peripherally mediated pain, offering broad therapeutic potential
• May alleviate pain in cases where conventional NSAIDs or opioids are less effective or contraindicated
• Demonstrates muscle relaxant properties, expanding clinical usefulness to additional neurological conditions
• Flexible administration routes possible (oral, intravenous, inhaled), improving patient compliance and treatment options
• Evidence from in vivo studies supports significant pain relief, lending credence to practical clinical value

Technical Classifications (CPCs)

Inventors & Applicants

Patent Abstract

The invention relates to novel compounds of amino-, imino-1,2,4 triazine derivatives of formula (I) and to the use of the same as medicament.